Status: Recruiting
Study of AT-587 in Healthy Subjects
This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-587 in healthy subjects
Participants needed: 62
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Atea Pharmaceuticals, Inc.Updated: Jul 27, 2026Locations: 1
Eligibility criteria
Body mass index (BMI) of 18-29 kg/m2 [+3]
Pregnant or breastfeeding [+3]